Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Liver Diseases

Free Subscription 03.06.2024 1 AJR Am J Roentgenol 2 Biochem Biophys Res Commun 1 BMC Gastroenterol 2 Clin Res Hepatol Gastroenterol 1 Dig Dis Sci 1 Endoscopy 4 Eur Radiol 2 Gastroenterology 3 Hepatology 12 Indian J Gastroenterol 1 J Clin Oncol 3 J Gastroenterol 2 J Gastroenterol Hepatol 1 J Hepatol 1 Minerva Gastroenterol (Torino) 4 N Engl J Med 2 PLoS One 1 Radiol Cardiothorac Imaging 2 Radiology

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

AJR Am J Roentgenol

1. 
   Correction for "Contrast-Enhanced Ultrasound Using Perfluorobutane: Impact of Proposed Modified LI-RADS Criteria on Hepatocellular Carcinoma Detection".
   AJR Am J Roentgenol. 2024 May 29:1. doi: 10.2214/AJR.24.31469.
   PubMed        
   
   

   
   Biochem Biophys Res Commun

2. WANG B, Zhu X, Yu S, Xue H, et al
   Roflumilast ameliorates GAN diet-induced non-alcoholic fatty liver disease by reducing hepatic steatosis and fibrosis in ob/ob mice.
   Biochem Biophys Res Commun. 2024;722:150170.
   PubMed         Abstract available
   
   
3. SHI X, Qi Z, Huang D, Zhu J, et al
   HuR facilitates miR-93-5p-induced activation of MAP3K2 translation via MAP3K2 3'UTR ARE2 in hepatocellular carcinoma.
   Biochem Biophys Res Commun. 2024;722:150152.
   PubMed         Abstract available
   
   

   
   BMC Gastroenterol

4. ELBADRY M, El-Raey F, Alboraie M, Abdel-Samiee M, et al
   Clinical and endoscopic characteristics of patients undergoing gastrointestinal endoscopic procedures in Egypt: a nationwide multicenter study.
   BMC Gastroenterol. 2024;24:186.
   PubMed         Abstract available
   
   

   
   Clin Res Hepatol Gastroenterol

5. MANSUR A, Grobman B, Lu CY
   Suicide risk is elevated among patients with chronic liver disease and cirrhosis in the United States.
   Clin Res Hepatol Gastroenterol. 2024;48:102378.
   PubMed        
   
   
6. CHANG G, Sun J, Li J, Li T, et al
   Effect of Probiotics on Portal Hypertension (PH) with Cirrhosis: A Systematic Review and Meta-Analysis.
   Clin Res Hepatol Gastroenterol. 2024 May 1:102361.
   PubMed         Abstract available
   
   

   
   Dig Dis Sci

7. ZHOU Y, Zhang Q, Kong Y, Guo X, et al
   Retraction Note: Insulin-Like Growth Factor Binding Protein-Related Protein 1 Activates Primary Hepatic Stellate Cells via Autophagy Regulated by the PI3K/Akt/mTOR Signaling Pathway.
   Dig Dis Sci. 2024 May 29. doi: 10.1007/s10620-024-08506.
   PubMed        
   
   

   
   Endoscopy

8. DHAR J, Bharath NP, Mahajan G, Bhujade H, et al
   Bleeding parastomal varices in a case of decompensated cirrhosis with tubercular abdominal cocoon: endoscopic ultrasound-guided angioembolization with coil and glue to the rescue.
   Endoscopy. 2024;56.
   PubMed        
   
   

   
   Eur Radiol

9. LEWIN M
   Can HCC postresection survival be predicted with prognostic MRI features?
   Eur Radiol. 2024;34:3160-3162.
   PubMed        
   
   
10. MENDIRATTA-LALA M, Aslam A, Bai HX, Chapiro J, et al
    Ethiodized oil as an imaging biomarker after conventional transarterial chemoembolization.
    Eur Radiol. 2024;34:3284-3297.
    PubMed         Abstract available
    
    
11. ZENSEN S, Bucker A, Meetschen M, Haubold J, et al
    Current use of percutaneous image-guided tumor ablation for the therapy of liver tumors: lessons learned from the registry of the German Society for Interventional Radiology and Minimally Invasive Therapy (DeGIR) 2018-2022.
    Eur Radiol. 2024;34:3322-3330.
    PubMed         Abstract available
    
    
12. VOUCHE M
    Large-scale data from real-life practice of percutaneous liver thermal ablation from an international registry: unconditionally trustful Atlas or colossus with feet of clay?
    Eur Radiol. 2024;34:3320-3321.
    PubMed        
    
    

    
    Gastroenterology

13. HANSCOM M
    Magnetically guided capsule endoscopy comparable to EGD for detecting esophagogastric varices in patients with cirrhosis.
    Gastroenterology. 2024 May 28:S0016-5085(24)05001.
    PubMed        
    
    
14. HILSCHER MB, Wysokinski WE, Andrews JC, Simonetto DA, et al
    Portal Vein Thrombosis in the Setting of Cirrhosis: Evaluation and Management Strategies.
    Gastroenterology. 2024 May 25:S0016-5085(24)04951.
    PubMed        
    
    

    
    Hepatology

15. MANTOVANI S, Mondelli MU
    Platelets harness innate immunity to promote dissemination of hepatocellular carcinoma.
    Hepatology. 2024 May 29. doi: 10.1097/HEP.0000000000000946.
    PubMed        
    
    
16. GUO C, Liu Z, Zhang T
    Reply: Regarding the use of decision curve analysis in predicting long-term complications of liver cirrhosis.
    Hepatology. 2024 May 29. doi: 10.1097/HEP.0000000000000947.
    PubMed        
    
    
17. MUSSO G, Pinach S, Mariano F, Saba F, et al
    Effect of phospholipid curcumin Meriva(R) on liver histology and kidney disease in nonalcoholic steatohepatitis a randomized, double-blind, placebo-controlled trial.
    Hepatology. 2024 May 28. doi: 10.1097/HEP.0000000000000937.
    PubMed         Abstract available
    
    

    
    Indian J Gastroenterol

18. KULKARNI AV, Zuberi AA, Chaitanya K, Doolam H, et al
    Human albumin infusion is safe and effective even in patients without acute kidney injury and spontaneous bacterial peritonitis.
    Indian J Gastroenterol. 2024;43:485-493.
    PubMed         Abstract available
    
    
19. GUPTA E, Samal J, Maiwall R, Tevethia H, et al
    Respiratory tract viral infections associated sepsis in patients with underlying liver disease: Viral sepsis an entity to look forward!
    Indian J Gastroenterol. 2024;43:475-484.
    PubMed         Abstract available
    
    
20. SAMANTA A, Poddar U
    Pediatric acute liver failure: Current perspective in etiology and management.
    Indian J Gastroenterol. 2024;43:349-360.
    PubMed         Abstract available
    
    
21. ZACHARIAH U, Vijayalekshmi B, Matthai SM, Goel A, et al
    Extra-corporeal non-liver transplant therapies for acute liver failure: Focus on plasma exchange and continuous renal replacement therapy.
    Indian J Gastroenterol. 2024;43:338-348.
    PubMed         Abstract available
    
    
22. SHARMA B, Bhateja A, Sharma R, Chauhan A, et al
    Acute kidney injury in acute liver failure: A narrative review.
    Indian J Gastroenterol. 2024;43:377-386.
    PubMed         Abstract available
    
    
23. SEHRAWAT SS, Premkumar M
    Critical care management of acute liver failure.
    Indian J Gastroenterol. 2024;43:361-376.
    PubMed         Abstract available
    
    
24. SINGH SA, Jadaun S, Gain A, Saigal S, et al
    Difficult transplant decisions in acute liver failure -Benefit versus futility, where to draw a line.
    Indian J Gastroenterol. 2024;43:522-526.
    PubMed        
    
    
25. GIRI S, Anirvan P, Vaidya A, Praharaj DL, et al
    Dengue-related acute liver failure-A scoping review.
    Indian J Gastroenterol. 2024;43:407-424.
    PubMed         Abstract available
    
    
26. SITHAMPARAPILLAI K, Zachariah U, Eapen CE, Goel A, et al
    Plasma exchange improves survival in acute liver failure - An updated systematic review and meta-analysis focussed on comparing within single etiology.
    Indian J Gastroenterol. 2024;43:397-406.
    PubMed         Abstract available
    
    
27. ALEXANDER V, Benjamin SJ, Subramani K, Sathyendra S, et al
    Acute liver failure in pregnancy.
    Indian J Gastroenterol. 2024;43:325-337.
    PubMed         Abstract available
    
    
28. ACHARYA SK
    Overview of acute liver failure in India.
    Indian J Gastroenterol. 2024;43:296-311.
    PubMed         Abstract available
    
    
29. GARG K, Jain AK, Nimje GR, Kajal K, et al
    Perioperative care in acute liver failure: An anaesthesiologist perspective in the operating theatre.
    Indian J Gastroenterol. 2024;43:387-396.
    PubMed         Abstract available
    
    

    
    J Clin Oncol

30. SANGRO B, Galle PR, Kelley RK, Charoentum C, et al
    Patient-Reported Outcomes From the Phase III HIMALAYA Study of Tremelimumab Plus Durvalumab in Unresectable Hepatocellular Carcinoma.
    J Clin Oncol. 2024 May 28:JCO2301462. doi: 10.1200/JCO.23.01462.
    PubMed         Abstract available
    
    

    
    J Gastroenterol

31. WAKABAYASHI SI, Tamaki N, Kimura T, Umemura T, et al
    Natural history of lean and non-lean metabolic dysfunction-associated steatotic liver disease.
    J Gastroenterol. 2024;59:494-503.
    PubMed         Abstract available
    
    
32. HIROOKA M, Ogawa S, Koizumi Y, Yoshida Y, et al
    iATT liver fat quantification for steatosis grading by referring to MRI proton density fat fraction: a multicenter study.
    J Gastroenterol. 2024;59:504-514.
    PubMed         Abstract available
    
    
33. MINO M, Sano A, Kakazu E, Matsubara H, et al
    Differences in branched-chain amino acid to tyrosine ratio (BTR) among etiologies of chronic liver disease progression compared to healthy adults.
    J Gastroenterol. 2024;59:483-493.
    PubMed         Abstract available
    
    

    
    J Gastroenterol Hepatol

34. SHIN SK, Oh S, Chun SK, Ahn MJ, et al
    Immune signature and therapeutic approach of natural killer cell in chronic liver disease and hepatocellular carcinoma.
    J Gastroenterol Hepatol. 2024 May 27. doi: 10.1111/jgh.16584.
    PubMed         Abstract available
    
    
35. SUN Z, Guo Y, Xu X, Zhou C, et al
    Hydronidone induces apoptosis in activated hepatic stellate cells through endoplasmic reticulum stress-associated mitochondrial apoptotic pathway.
    J Gastroenterol Hepatol. 2024 May 28. doi: 10.1111/jgh.16635.
    PubMed         Abstract available
    
    

    
    J Hepatol

36. ROY A, Tewari A, Sonthalia N, Chand Ghoshal U, et al
    Identifying Predictors of Acute and Non-acute Decompensation in a Cohort of MASLD Predominant Cirrhosis.
    J Hepatol. 2024 May 24:S0168-8278(24)00363-5. doi: 10.1016/j.jhep.2024.
    PubMed        
    
    

    
    Minerva Gastroenterol (Torino)

37. WANG Q, Chen X, Li H, Hua F, et al
    Analysis of metabolic indexes in patients with type 2 diabetes and metabolic associated fatty liver disease.
    Minerva Gastroenterol (Torino). 2024;70:252-253.
    PubMed        
    
    

    
    N Engl J Med

38. KOWDLEY KV, Levy C, Jones D
    Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis. Reply.
    N Engl J Med. 2024;390:1935-1936.
    PubMed        
    
    
39. HIRSCHFIELD GM, Kremer AE, Levy C
    Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis. Reply.
    N Engl J Med. 2024;390:1934-1935.
    PubMed        
    
    
40. IJICHI H
    Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis.
    N Engl J Med. 2024;390:1934.
    PubMed        
    
    
41. AREVALO-CANAS C, Arevalo-Serrano J
    Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis.
    N Engl J Med. 2024;390:1933-1934.
    PubMed        
    
    

    
    PLoS One

42. SHI H, Xu H, Huang S, Tan Z, et al
    Gender disparity between first and senior authors on liver cancer research in the top journals of Gastroenterology and Hepatology.
    PLoS One. 2024;19:e0295648.
    PubMed         Abstract available
    
    
43. LU J, Feng Y, Guo K, Sun L, et al
    Association between human blood metabolome and the risk of gastrointestinal tumors.
    PLoS One. 2024;19:e0304574.
    PubMed         Abstract available
    
    

    
    Radiol Cardiothorac Imaging

44. TANDON R, Agakishiev D, Freese RL, Thompson J, et al
    Heart Rate Lowering for Coronary CTA with Ivabradine in End-Stage Liver Disease.
    Radiol Cardiothorac Imaging. 2024;6:e230402.
    PubMed        
    
    

    
    Radiology

45. LYSHCHIK A, Fetzer DT, Kono Y, Wilson SR, et al
    Liver Imaging Reporting and Data System Contrast-Enhanced US Nonradiation Treatment Response Assessment Version 2024.
    Radiology. 2024;311:e232369.
    PubMed         Abstract available
    
    
46. MILOT L
    Hepatocellular Carcinoma Assessment after Locoregional Treatment: A Primer on LI-RADS Contrast-Enhanced Nonradiation Treatment Response Assessment Version 2024.
    Radiology. 2024;311:e240124.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.